DXR 0.00 Daxor Corporation
| Range: | 7.11-10.04 | Vol Avg: | 5754 | Last Div: | 0 | Changes: | -0.07 |
| Beta: | -0.55 | Cap: | 0.04B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Mon Jul 25 1983 | Empoloyees: | 37 | ||
| CUSIP: | 239467103 | CIK: | 0000027367 | ISIN: | US2394671034 | Country: | US |
| CEO: | Mr. Michael Richard Feldschuh | Website: | https://www.daxor.com | ||||
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Stock Details
Positive 0.55
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept....
globenewswire.com·Fri Sep 27 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow